Literature DB >> 15598684

Insulin-like growth factor binding protein-1 is independently affected by ethnicity, insulin sensitivity, and leptin in healthy, glucose-tolerant young men.

Choon F Liew1, Stephen D Wise, Kwee P Yeo, Kok O Lee.   

Abstract

We examined the relationships among IGF binding protein (IGFBP)-1, insulin sensitivity, and leptin in different ethnic groups (Asian Indians, Chinese, and Caucasians) using the euglycemic hyperinsulinemic clamp. Ten healthy, young and nondiabetic subjects of each ethnic group, matched for body mass index, age, and physical activity were studied. A euglycemic clamp was performed on all subjects. IGFBP-1, insulin, and leptin were measured after fasting and during the clamp. Fasting IGFBP-1 concentration was highest in Chinese (P = 0.027). Asian Indians had the lowest insulin sensitivity index (P = 0.006). The ratio of insulin to IGFBP-1 at fasting and throughout the euglycemic clamp was higher in Asian Indians. Fasting IGFBP-1 had a strong negative correlation with fasting leptin levels (r = -0.715, P = 0.001). Multiple linear regression demonstrated that fasting insulin, leptin, ethnicity, and insulin sensitivity were significant predictors for fasting IGFBP-1. IGFBP-1 is independently determined by ethnicity, insulin sensitivity, and leptin in glucose-tolerant men. The presence of relative insulin resistance and low fasting IGFBP-1 levels in Asian Indians may contribute to their higher risk of developing diabetes and cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15598684     DOI: 10.1210/jc.2004-1501

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  10 in total

Review 1.  The role of insulin-like growth factor-I and its binding proteins in glucose homeostasis and type 2 diabetes.

Authors:  Swapnil N Rajpathak; Marc J Gunter; Judith Wylie-Rosett; Gloria Y F Ho; Robert C Kaplan; Radhika Muzumdar; Thomas E Rohan; Howard D Strickler
Journal:  Diabetes Metab Res Rev       Date:  2009-01       Impact factor: 4.876

2.  Longitudinal analysis of the insulin-like growth factor system in African-American and European American children and adolescents.

Authors:  Krista Casazza; Paul B Higgins; José R Fernández; Michael I Goran; Barbara A Gower
Journal:  J Clin Endocrinol Metab       Date:  2008-09-09       Impact factor: 5.958

3.  Insulin-like growth factor-binding protein-1 in the prediction and development of type 2 diabetes in middle-aged Swedish men.

Authors:  M S Lewitt; A Hilding; C-G Ostenson; S Efendic; K Brismar; K Hall
Journal:  Diabetologia       Date:  2008-05-22       Impact factor: 10.122

4.  Identification and Validation of Nutrient State-Dependent Serum Protein Mediators of Human CD4+ T Cell Responsiveness.

Authors:  Kim Han; Komudi Singh; Matthew J Rodman; Shahin Hassanzadeh; Yvonne Baumer; Rebecca D Huffstutler; Jinguo Chen; Julián Candia; Foo Cheung; Katherine E R Stagliano; Mehdi Pirooznia; Tiffany M Powell-Wiley; Michael N Sack
Journal:  Nutrients       Date:  2021-04-28       Impact factor: 5.717

5.  Increasing circulating IGFBP1 levels improves insulin sensitivity, promotes nitric oxide production, lowers blood pressure, and protects against atherosclerosis.

Authors:  Adil Rajwani; Vivienne Ezzat; Jessica Smith; Nadira Y Yuldasheva; Edward R Duncan; Matthew Gage; Richard M Cubbon; Matthew B Kahn; Helen Imrie; Afroze Abbas; Hema Viswambharan; Amir Aziz; Piruthivi Sukumar; Antonio Vidal-Puig; Jaswinder K Sethi; Shouhong Xuan; Ajay M Shah; Peter J Grant; Karen E Porter; Mark T Kearney; Stephen B Wheatcroft
Journal:  Diabetes       Date:  2012-02-22       Impact factor: 9.461

Review 6.  The insulin like growth factor and binding protein family: Novel therapeutic targets in obesity & diabetes.

Authors:  Natalie J Haywood; Thomas A Slater; Connor J Matthews; Stephen B Wheatcroft
Journal:  Mol Metab       Date:  2018-10-24       Impact factor: 7.422

Review 7.  Use of sodium-glucose co-transporter-2 inhibitors in patients with type 2 diabetes mellitus and multiple cardiovascular risk factors: An Asian perspective and expert recommendations.

Authors:  Chaicharn Deerochanawong; Siew P Chan; Bien J Matawaran; Wayne H-H Sheu; Juliana Chan; Nguyen H Man; Ketut Suastika; Chin M Khoo; Kun-Ho Yoon; Andrea Luk; Ambrish Mithal; Ji Linong
Journal:  Diabetes Obes Metab       Date:  2019-07-17       Impact factor: 6.577

8.  Dual GIP and GLP-1 Receptor Agonist Tirzepatide Improves Beta-cell Function and Insulin Sensitivity in Type 2 Diabetes.

Authors:  Melissa K Thomas; Amir Nikooienejad; Ross Bray; Xuewei Cui; Jonathan Wilson; Kevin Duffin; Zvonko Milicevic; Axel Haupt; Deborah A Robins
Journal:  J Clin Endocrinol Metab       Date:  2021-01-23       Impact factor: 5.958

9.  Profiling of Insulin-Like Growth Factor Binding Proteins (IGFBPs) in Obesity and Their Association With Ox-LDL and Hs-CRP in Adolescents.

Authors:  Abdur Rahman; Maha M Hammad; Irina Al Khairi; Preethi Cherian; Reem Al-Sabah; Fahd Al-Mulla; Mohamed Abu-Farha; Jehad Abubaker
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-28       Impact factor: 5.555

10.  Growth factors and adipocytokines in prepubertal children born small for gestational age: relation to insulin resistance.

Authors:  Anna S Challa; Eleni N Evagelidou; Vasilios I Cholevas; Dimitrios N Kiortsis; Vasileios I Giapros; Aikaterini A Drougia; Styliani K Andronikou
Journal:  Diabetes Care       Date:  2009-01-08       Impact factor: 17.152

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.